Holen Sie sich die Stockscreener-App
1.02
10.53%
-0.12
Handel nachbörslich:
1.08
0.06
+5.88%
Schlusskurs vom Vortag:
$1.14
Offen:
$1.12
24-Stunden-Volumen:
59,641
Relative Volume:
0.93
Marktkapitalisierung:
$10.31M
Einnahmen:
$1.52M
Nettoeinkommen (Verlust:
$-70.60M
KGV:
-1.2143
EPS:
-0.84
Netto-Cashflow:
$-57.34M
1W Leistung:
-8.93%
1M Leistung:
-1.92%
6M Leistung:
-43.02%
1J Leistung:
+367.89%
1-Tages-Spanne:
$1.01
$1.12
1-Wochen-Bereich:
$1.01
$1.21
52-Wochen-Spanne:
$0.20
$4.44
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Vergleichen Sie PAVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PAVM | 1.02 | 10.31M | 1.52M | -70.60M | -57.34M | -0.84 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PR Newswire
PAVmed Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
LUCDLucid Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript - Insider Monkey
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring By GuruFocus - Investing.com Canada
PAVmed Inc (PAVM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Restructuring - Yahoo Finance
First Manhattan Co. LLC's Strategic Acquisition of PAVmed Inc Sh - GuruFocus.com
PAVmed Inc. (PAVM) Quarterly 10-Q Report - Quartzy
PAVmed Inc Reports Q3 2024 Earnings: Revenue at $996,000, Non-GA - GuruFocus.com
PAVmed Reports Record Revenue and Strategic Restructuring - TipRanks
PAVmed Provides Business Update and Third Quarter 2024 Financial Results - PR Newswire
PAVMPAVmed Inc. Latest Stock News & Market Updates - StockTitan
Lucid Diagnostics' EsoGuard Revenue Surges 50% YoY, Sets Record Testing Volume in Q3 | PAVM Stock News - StockTitan
Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results - Nasdaq
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication – Company AnnouncementFT.com - Financial Times
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - Yahoo Finance
Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers - BioSpace
Lucid Diagnostics expands direct contracting for cancer testing - Investing.com
Lucid Diagnostics expands direct contracting for cancer testing By Investing.com - Investing.com Canada
Lucid Diagnostics Expands EsoGuard Testing, Lands Major Firefighter Contract | PAVM Stock News - StockTitan
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024 - GuruFocus.com
PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024 - Kilgore News Herald
Lucid Diagnostics to Participate in Upcoming Investor Conferences - GuruFocus.com
Lucid Diagnostics gets notice of allowance for patent underlying its esoguard esophageal DNA test - MSN
Veris Health receives $1.8M NIH grant for cancer care - Mobihealth News
Lucid Diagnostics secures US patent for esophageal cancer test - Investing.com
Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test - Quantisnow
Lucid Diagnostics stock maintains Buy rating from BTIG - Investing.com India
Lucid Diagnostics stock maintains Buy rating from BTIG By Investing.com - Investing.com South Africa
PAVmed, Veris Health get USD 1.8M NIH grant - Medical Buyer
PAVmed subsidiary receives $1.8 million NIH grant for cancer care By Investing.com - Investing.com South Africa
PAVmed subsidiary receives $1.8 million NIH grant for cancer care - Investing.com India
PAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH Grant to Enhance Cancer Care - PR Newswire
Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit - PR Newswire
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024 - StreetInsider.com
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024 – Company Announcement - Financial Times
Contrasting enVVeno Medical (NASDAQ:NVNO) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players - Financial Times
Lucid Diagnostics Announces Multiple Presentations at the Upcomi - GuruFocus.com
Lucid Diagnostics Strengthens and Expands Market Access and Dire - GuruFocus.com
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test - StockTitan
Pavna Industries Ltd leads gainers in 'B' group - Business Standard
Sound Shore Management Inc. CT Trims Holdings in PVH Corp. (NYSE:PVH) - Defense World
Palantir Skids Despite Winning Army Contract - Baystreet.ca
Palantir Wins Multimillion-Dollar Deal to Expand Maven Smart System to U.S. Army, Air Force, Space Force and - The Bharat Express News
Palantir Wins Deal Worth Multi-Million Dollars To Expand Maven Smart System Across US Army, Air Force, Space Force & Navy - Yahoo Finance
Palantir announces $99.8M contract award by DEVCOM Army Research Laboratory - Seeking Alpha
Hsbc Holdings PLC Boosts Stock Holdings in PDD Holdings Inc. (NASDAQ:PDD) - MarketBeat
SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq - Business Wire
PAVmed moves to deconsolidate Lucid Diagnostics - Investing.com India
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):